<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04350008</url>
  </required_header>
  <id_info>
    <org_study_id>BA112</org_study_id>
    <nct_id>NCT04350008</nct_id>
  </id_info>
  <brief_title>BIO|CONCEPT.Renamic Neo Study</brief_title>
  <official_title>BIO|CONCEPT.Renamic Neo</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Biotronik SE &amp; Co. KG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Biotronik SE &amp; Co. KG</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The BIO|CONCEPT.Renamic.Neo study is designed as a pre-market study to provide clinical data
      and supporting evidence of the safety, performance and usability of the Renamic Neo
      programmer system.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 8, 2020</start_date>
  <completion_date type="Anticipated">October 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">July 31, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of adverse device effects / device deficiencies per number of implantations</measure>
    <time_frame>Patients participate from (I) implantation until the pre-hospital discharge (normally 2-3 days) or (II) only for the in-office follow-up (1 day).</time_frame>
    <description>The number of adverse device effects (ADE) and device deficiencies (DD) that occur in patients, users or other persons will be evaluated. The investigator is asked to report any ADEs or DD that occurred during implantations.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of adverse device Effects / device deficiencies and per number of follow-up cases</measure>
    <time_frame>Patients participate from (I) implantation until the pre-hospital discharge (normally 2-3 days) or (II) only for the in-office follow-up (1 day).</time_frame>
    <description>The number of adverse device effects and device deficiencies (DD) that occur in patients, users or other persons will be evaluated. The investigator is asked to report any ADEs or DD that occurred during follow-ups.</description>
  </primary_outcome>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Medical Devices</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Renamic Neo programmer device, including software; PK-222-L ECG cable</intervention_name>
    <description>Patients will be enrolled either for implantation including subsequent pre-hospital discharge or for a follow-up visit only. ICM patients will be included for follow-ups only. Implants will be programmed and interrogated by using the investigational devices.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients that are planned to receive or are already implanted with a programmable BIOTRONIK
        cardiac rhythm management (CRM) device.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient is planned for de novo implantation or already has a BIOTRONIK active,
             implantable device.

          -  Patient is able to understand the nature of the study and provides written informed
             consent.

        Exclusion Criteria:

          -  Patient is implanted with a Stratos pacemaker.

          -  Patient is planned for implant exchange or upgrade.

          -  Patient is pregnant or breast feeding.

          -  Patient is less than 18 years old.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Doerte Vossmeyer, Dr.</last_name>
    <phone>+493068905</phone>
    <phone_ext>0</phone_ext>
    <email>renamicneoconcept@biotronik.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Royal Adelaide Hospital</name>
      <address>
        <city>Adelaide</city>
        <country>Australia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Dennis Lau, Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>GenesisCare Wesley</name>
      <address>
        <city>Auchenflower</city>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephen Pavia, Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>GenesisCare Bundaberg</name>
      <address>
        <city>Bundaberg</city>
        <country>Australia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Andre Conradie, Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Canberra Hospital</name>
      <address>
        <city>Canberra</city>
        <country>Australia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Rajeev Pathak</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Lyell McEwin Hospital (LMH)</name>
      <address>
        <city>Elizabeth Vale</city>
        <country>Australia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Margaret Anne Arstall</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Liverpool Hospital</name>
      <address>
        <city>Liverpool</city>
        <country>Australia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Hany Dimitri, Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Monash Medical Centre</name>
      <address>
        <city>Melbourne</city>
        <country>Australia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Stewart Healy, Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mulgrave Private Hospital</name>
      <address>
        <city>Mulgrave</city>
        <country>Australia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Matt Swale, Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>John Hunter Hospital</name>
      <address>
        <city>New Lambton Heights</city>
        <country>Australia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Nicholas Jackson</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Australia</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>April 14, 2020</study_first_submitted>
  <study_first_submitted_qc>April 14, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 16, 2020</study_first_posted>
  <last_update_submitted>June 9, 2020</last_update_submitted>
  <last_update_submitted_qc>June 9, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 11, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

